Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters

American Journal of Hematology

Volumn 89, Issue 4, 2014, Pages 369-374

  Raess, Philipp W ^a   van de Geijn, Gert Jan M ^b   Njo, Tjin L ^b   Klop, Boudewijn ^b   Sukhachev, Dmitry ^c   Wertheim, Gerald ^a,d   Mcaleer, Tom ^a   Master, Stephen R ^a   Bagg, Adam ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

^c Department of Internal Medicine Diabetes and Vascular Center Sint Franciscus Gasthuis ^*

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BONE MARROW BIOPSY; CELL POPULATION; DIAGNOSTIC TEST ACCURACY STUDY; ERYTHROCYTE; FEASIBILITY STUDY; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMATOLOGY ANALYZER; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

AGED; ALGORITHMS; AREA UNDER CURVE; BLOOD CELL COUNT; BLOOD PLATELETS; BONE MARROW; BONE MARROW EXAMINATION; CELL SIZE; COHORT STUDIES; DECISION TREES; ELECTRIC IMPEDANCE; ERYTHROCYTE INDICES; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OUTPATIENTS; RANDOM ALLOCATION; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84897472101     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23643     Document Type: Article

References (33)

1. Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC Press; 2008.
2. Naqvi K, Jabbour E, Bueso-Ramos C, et al. Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers. Blood 2011;118:4690-4693.
3. Khan AM. Why are myelodysplastic syndromes unrecognized and underdiagnosed? A primary care perspective. Am J Med 2012;125:S15-S17.
4. Greenberg PL. Molecular and genetic features of myelodysplastic syndromes. Int J Lab Hematol 2012;34:215-222.
5. Chaves F, Tierno B, Xu D. Quantitative determination of neutrophil VCS parameters by the Coulter automated hematology analyzer: New and reliable indicators for acute bacterial infection. Am J Clin Pathol 2005;124:440-444.
6. Chaves F, Tierno B, Xu D. Neutrophil volume distribution width: A new automated hematologic parameter for acute infection. Arch Pathol Lab Med 2006;130:378-380.
7. Bagdasaryan R, Zhou Z, Tierno B, et al. Neutrophil VCS parameters are superior indicators for acute infection. Lab Hematol 2007;13:12-16.
8. Lee JC, Ahern TP, Chaves FP, et al. Utility of hematologic and volume, conductivity, and scatter parameters from umbilical cord blood in predicting chorioamnionitis. Int J Lab Hematol 2010;32:351-359.
9. Mardi D, Fwity B, Lobmann R, et al. Mean cell volume of neutrophils and monocytes compared with C-reactive protein, interleukin-6 and white blood cell count for prediction of sepsis and nonsystemic bacterial infections. Int J Lab Hematol 2010;32:410-418.
10. Charafeddine KM, Youssef AM, Mahfouz RA, et al. Comparison of neutrophil volume distribution width to C-reactive protein and procalcitonin as a proposed new marker of acute infection. Scand J Infect Dis 2011;43:777-784.
11. Celik IH, Demirel G, Aksoy HT, et al. Automated determination of neutrophil VCS parameters in diagnosis and treatment efficacy of neonatal sepsis. Pediatr Res 2012;71:121-125.
12. Nierhaus A, Linssen J, Wichmann D, et al. Use of a weighted, automated analysis of the differential blood count to differentiate sepsis from non-infectious systemic inflammation: the intensive care infection score (ICIS). Inflamm Allergy Drug Targets 2012;11:109-115.
13. Zhu Y, Cao X, Chen Y, et al. Neutrophil cell population data: Useful indicators for postsurgical bacterial infection. Int J Lab Hematol 2012;34:295-299.
14. Silva M, Fourcade C, Fartoukh C, et al. Lymphocyte volume and conductivity indices of the haematology analyser Coulter GEN.S in lymphoproliferative disorders and viral diseases. Clin Lab Haematol 2006;28:1-8.
15. Campuzano-Zuluaga G, Hanscheid T, Grobusch MP. Automated haematology analysis to diagnose malaria. Malar J 2010;9:346.
16. Leckie MJ, Bryan SA, Khan J, et al. Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients. Thorax 2000;55:471-477.
17. Velthove KJ, van Solinge WW, Lammers JW, et al. Hematocytometry analysis as discriminative marker for asthma phenotypes. Clin Chem Lab Med 2009;47:573-578.
18. Leckie MJ, Gomma AH, Purcell IF, et al. Automated quantitation of peripheral blood neutrophil activation in patients with myocardial ischaemia. Int J Cardiol 2004;95:307-313.
19. Klop B, van de Geijn GJ, Njo TL, et al. Leukocyte cell population data (volume conductivity scatter) in postprandial leukocyte activation. Int J Lab Hematol 2013;35:644-651.
20. Haschke-Becher E, Vockenhuber M, Niedetzky P, et al. A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndrome. Clin Chem Lab Med 2008;46:85-88.
21. Jean A, Boutet C, Lenormand B, et al. Combination of cellular population data and CytoDiff analyses for the diagnosis of lymphocytosis. Clin Chem Lab Med 2011;49:1861-1868.
22. Rappaport ES, Helbert B, Ladd DJ, et al. Myelodysplastic syndrome: Identification in the routine hematology laboratory. South Med J 1987;80:969-974.
23. Orazi A, Milanesi B. The technicon H6000 automated hematology analyzer in the diagnosis and classification of the myelodysplastic syndromes. Haematologica 1990;75:87-90.
24. Miguel A, Orero M, Simon R, et al. Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia. Lab Hematol 2007;13:98-102.
25. Furundarena JR, Araiz M, Uranga M, et al. The utility of the Sysmex XE-2100 analyzer's NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes. Int J Lab Hematol 2010;32:360-366.
26. Rocco V, Maconi M, Gioia M, et al. Possibility of myelodysplastic syndromes screening using a complete blood automated cell count. Leuk Res 2011;35:1623-1627.
27. Liaw A, Wiener M. Classification and regression by randomForest. R News 2002;2:18-22.
28. Team RC. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
29. Khalilia M, Chakraborty S, Popescu M. Predicting disease risks from highly imbalanced data using random forest. BMC Med Inform Decis Mak 2011;11:51.
30. Sing T, Sander O, Beerenwinkel N, et al. Visualizing the performance of scoring classifiers. R package version 10-4 2009.
31. Chen X, Wang M, Zhang H. The use of classification trees for bioinformatics. Wiley Interdiscip Rev Data Min Knowl Discov 2011;1:55-63.
32. Le Roux G, Vlad A, Eclache V, et al. Routine diagnostic procedures of myelodysplastic syndromes: Value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100. Int J Lab Hematol 2010;32:e237-e243.
33. Inaba T, Yuki Y, Yuasa S, et al. Clinical utility of the neutrophil distribution pattern obtained using the CELL-DYN SAPPHIRE hematology analyzer for the diagnosis of myelodysplastic syndrome. Int J Hematol 2011;94:169-177.